secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2026-03-18T23:59:59+00:00
Accession:  0001628280-26-019455
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Mary Rotunno resigns from Vistagen Therapeutics board effective April 1, 2026
-----------------------------------------------------------------------------

- Mary Rotunno resigned from the Board of Directors on March 17, 2026, effective April 1, 2026.
- No reason for resignation or replacement disclosed in the filing.
- Resignation reported under Item 5.02; no other executive changes mentioned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000162828026019455/0001628280-26-019455-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000162828026019455/vtgn-20260317.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-019455

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer